This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
amino acid | 924 |
amino acids | 884 |
mannich bases | 841 |
mg kg | 609 |
cell lines | 606 |
results suggest | 500 |
antiviral activity | 488 |
antimicrobial activity | 473 |
present study | 455 |
antibacterial activity | 451 |
mg ml | 424 |
inhibitory activity | 412 |
cell line | 408 |
gene expression | 397 |
oxidative stress | 395 |
cancer cells | 363 |
biological activity | 360 |
natural products | 317 |
physical activity | 316 |
essential oils | 299 |
breast cancer | 295 |
cell death | 292 |
important role | 287 |
antioxidant activity | 283 |
antimicrobial peptides | 282 |
antifungal activity | 275 |
research funds | 268 |
cancer cell | 266 |
active site | 260 |
mass spectrometry | 257 |
control group | 246 |
nervous system | 219 |
cell proliferation | 218 |
pomegranate juice | 218 |
reference drug | 217 |
results indicate | 214 |
escherichia coli | 204 |
molecular weight | 202 |
graduate school | 199 |
wild type | 195 |
dependent manner | 194 |
essential oil | 193 |
biological activities | 191 |
fatty acids | 190 |
results showed | 189 |
psoralea corylifolia | 189 |
protein kinase | 186 |
wide range | 186 |
ic values | 184 |
binding site | 184 |
cell cycle | 183 |
influenza virus | 178 |
spinal cord | 176 |
inhibitory effect | 175 |
medicinal plants | 172 |
ng ml | 169 |
nitric oxide | 166 |
solid phase | 165 |
side chain | 160 |
side effects | 160 |
cell surface | 160 |
prostate cancer | 159 |
endothelial cells | 157 |
enzyme activity | 156 |
cell membrane | 154 |
reactive oxygen | 154 |
mannich base | 153 |
staphylococcus aureus | 152 |
widely used | 149 |
plasma membrane | 149 |
previous studies | 149 |
stem cells | 148 |
growth factor | 146 |
dna damage | 145 |
oxygen species | 144 |
punica granatum | 144 |
peptide synthesis | 141 |
tumor cells | 140 |
protein expression | 140 |
central nervous | 139 |
blood pressure | 138 |
clinical trials | 137 |
fatty acid | 136 |
transcription factor | 136 |
acid residues | 136 |
lipid peroxidation | 136 |
two different | 135 |
immune system | 135 |
antimicrobial peptide | 135 |
creative tourism | 134 |
herpes simplex | 132 |
molecular mechanisms | 132 |
signi fi | 132 |
cell culture | 132 |
type i | 131 |
significantly increased | 131 |
immune response | 130 |
negative bacteria | 129 |
secondary structure | 127 |
results show | 127 |
mrna expression | 126 |
significantly higher | 126 |
western blot | 125 |
signal transduction | 125 |
recent studies | 125 |
cell viability | 124 |
coumarin derivatives | 122 |
plant extracts | 121 |
first day | 121 |
transcription factors | 121 |
molecular dynamics | 120 |
inhibitory effects | 119 |
flow cytometry | 118 |
body weight | 117 |
studies showed | 116 |
simplex virus | 116 |
cordyceps sinensis | 115 |
naturally occurring | 115 |
binding sites | 114 |
trypsin inhibitor | 114 |
cell cultures | 113 |
doc id | 112 |
cord uid | 112 |
large number | 112 |
signaling pathways | 111 |
protein synthesis | 111 |
biologically active | 111 |
significant difference | 110 |
binding protein | 108 |
secondary metabolites | 108 |
bioactive compounds | 107 |
cell wall | 107 |
activity relationship | 107 |
recent years | 107 |
high affinity | 106 |
smooth muscle | 106 |
cell growth | 106 |
molecular docking | 105 |
side chains | 104 |
ms ms | 103 |
antiviral agents | 103 |
affi nity | 103 |
oral administration | 103 |
expression levels | 102 |
blood samples | 102 |
data suggest | 102 |
also found | 102 |
epithelial cells | 102 |
significant increase | 102 |
antiviral activities | 101 |
national institute | 100 |
reverse transcriptase | 99 |
platelet aggregation | 99 |
crystal structure | 98 |
positive bacteria | 98 |
diabetes mellitus | 98 |
rna chaperone | 97 |
analysis revealed | 97 |
results obtained | 97 |
cell adhesion | 97 |
membrane proteins | 96 |
type ii | 96 |
antimicrobial activities | 95 |
statistically significant | 95 |
previously reported | 95 |
significantly reduced | 94 |
taken together | 94 |
serine protease | 94 |
lg ml | 94 |
biological evaluation | 94 |
significant differences | 93 |
first time | 93 |
cytotoxic activity | 93 |
conformational changes | 93 |
gel electrophoresis | 92 |
also known | 92 |
different types | 91 |
well known | 91 |
mouse model | 91 |
ic value | 91 |
mammalian cells | 90 |
virus replication | 90 |
th day | 90 |
significantly decreased | 90 |
also showed | 90 |
acid sequence | 89 |
active compounds | 89 |
protease inhibitors | 88 |
bases derived | 88 |
animal models | 88 |
type diabetes | 88 |
radical scavenging | 88 |
binding affinity | 87 |
protein interactions | 87 |
signaling pathway | 87 |
risk factors | 87 |
terminal domain | 87 |
inflammatory activity | 86 |
mic values | 86 |
protective effect | 86 |
key role | 86 |
electron microscopy | 85 |
drug resistance | 85 |
drug discovery | 85 |
results indicated | 85 |
free radical | 85 |
candida albicans | 85 |
growth inhibition | 85 |
antimicrobial agents | 85 |
dna binding | 84 |
membrane potential | 84 |
chaperone activity | 83 |
commonly used | 83 |
phenolic compounds | 83 |
present work | 83 |
ca i | 83 |
nmr spectroscopy | 83 |
may play | 83 |
modifi ed | 83 |
mycobacterium tuberculosis | 83 |
may contribute | 81 |
activity relationships | 81 |
enzymatic activity | 81 |
small molecule | 81 |
performed using | 81 |
chemical composition | 81 |
lung cancer | 81 |
amino group | 81 |
human rhinovirus | 80 |
liquid chromatography | 80 |
diabetic rats | 80 |
virus type | 80 |
cell types | 80 |
public health | 80 |
phase peptide | 80 |
broad spectrum | 80 |
pomegranate fruit | 79 |
superoxide dismutase | 79 |
stem cell | 79 |
viral infections | 78 |
cerebral cortex | 78 |
activated protein | 78 |
commercially available | 78 |
anticancer activity | 78 |
antimalarial activity | 77 |
hydroxyl group | 77 |
findings suggest | 77 |
therapeutic agents | 77 |
low molecular | 77 |
circular dichroism | 77 |
molecular biology | 77 |
fold higher | 77 |
hela cells | 76 |
fi rst | 76 |
phenolic mannich | 76 |
rat brain | 76 |
heart failure | 76 |
also observed | 76 |
progenitor cells | 76 |
wistar rats | 76 |
results suggested | 75 |
antioxidant capacity | 75 |
eucalyptus camaldulensis | 75 |
membrane protein | 75 |
showed significant | 75 |
docking studies | 75 |
expression level | 74 |
virus infection | 74 |
highly conserved | 74 |
protein levels | 74 |
drug delivery | 73 |
negatively charged | 73 |
blood glucose | 73 |
neuronal activity | 73 |
tumor cell | 73 |
metal ions | 73 |
small molecules | 73 |
mannich reaction | 73 |
vitro activity | 72 |
synthesized compounds | 72 |
insulin resistance | 72 |
necrosis factor | 72 |
may also | 72 |
research institute | 72 |
living cells | 72 |
binding domain | 71 |
colon cancer | 71 |
building blocks | 71 |
viral replication | 71 |
chemical synthesis | 71 |
ellagic acid | 71 |
neurodegenerative diseases | 71 |
fi cantly | 71 |
high levels | 70 |
affinity chromatography | 70 |
inhibitory concentration | 70 |
functional groups | 70 |
angiotensin ii | 70 |
seed oil | 70 |
gallic acid | 70 |
catalytic activity | 69 |
plasmodium falciparum | 69 |
first step | 69 |
infectious diseases | 69 |
antiproliferative activity | 69 |
closely related | 69 |
high activity | 69 |
assay system | 69 |
purkinje cells | 69 |
colorectal cancer | 69 |
bacillus subtilis | 69 |
protein structure | 68 |
marine natural | 68 |
blot analysis | 68 |
receptor antagonist | 68 |
infected cells | 68 |
nmda receptor | 68 |
host cells | 68 |
converting enzyme | 68 |
respiratory tract | 68 |
skeletal muscle | 67 |
compounds showed | 67 |
new class | 67 |
immunodeficiency virus | 67 |
human breast | 67 |
hippocampal neurons | 66 |
significantly lower | 66 |
coupled receptors | 66 |
united states | 66 |
analysis showed | 66 |
bone marrow | 66 |
adverse effects | 66 |
synthetic peptides | 66 |
recombinant protein | 66 |
positive control | 66 |
extracellular matrix | 65 |
different concentrations | 65 |
drug development | 65 |
three different | 65 |
natural compounds | 65 |
also used | 65 |
resistant strains | 65 |
scavenging activity | 65 |
cyclic peptides | 65 |
cell migration | 65 |
antitumor activity | 65 |
prefrontal cortex | 64 |
pseudomonas aeruginosa | 64 |
knockout mice | 64 |
ecklonia cava | 64 |
data indicate | 64 |
nucleic acid | 64 |
serine proteases | 64 |
binding proteins | 64 |
mechanisms underlying | 64 |
lactic acid | 64 |
determined using | 64 |
identifi ed | 64 |
crucial role | 63 |
model system | 63 |
saccharomyces cerevisiae | 63 |
protein kinases | 63 |
human immunodeficiency | 63 |
synaptic transmission | 63 |
molecular mass | 63 |
transgenic mice | 63 |
nuclear factor | 62 |
host cell | 62 |
cell membranes | 62 |
kg day | 62 |
poorly understood | 62 |
silver nanoparticles | 62 |
tumor necrosis | 62 |
carboxylic acid | 62 |
potent inhibitors | 62 |
brain science | 62 |
weight loss | 62 |
molecular mechanism | 62 |
vitro studies | 61 |
synthetic peptide | 61 |
phenyl ring | 61 |
day compared | 61 |
receptor binding | 61 |
whole blood | 61 |
deficient mice | 61 |
results demonstrate | 61 |
bglu activity | 61 |
current study | 61 |
animal model | 61 |
human plasma | 61 |
fusion protein | 61 |
fl uorescence | 60 |
western blotting | 60 |
viral rna | 60 |
positively charged | 60 |
drug design | 60 |
protease activity | 60 |
situ hybridization | 60 |
time pcr | 60 |
effi cient | 59 |
acute respiratory | 59 |
lipid bilayer | 59 |
myocardial infarction | 59 |
acetic acid | 59 |
muscle cells | 59 |
acid derivatives | 59 |
phase synthesis | 59 |
ang ii | 59 |
signifi cant | 59 |
antifungal activities | 59 |
mtt assay | 58 |
visual cortex | 58 |
cytotoxic effects | 58 |
protective effects | 58 |
previous study | 58 |
viral infection | 58 |
enzyme activities | 58 |
cellular processes | 58 |
hek cells | 58 |
antiviral drugs | 58 |
less active | 58 |
studies revealed | 57 |
substrate specificity | 57 |
respiratory syndrome | 57 |
fi cant | 57 |
therapeutic potential | 57 |
important roles | 57 |
results revealed | 57 |
several studies | 57 |
derivatives synthesis | 57 |
may lead | 57 |
common cold | 57 |
cortical neurons | 56 |
pomegranate extract | 56 |
protein folding | 56 |
magnetic resonance | 56 |
induced apoptosis | 56 |
antiviral effects | 56 |
may provide | 56 |
antioxidant properties | 56 |
another study | 56 |
potent anti | 56 |
heat shock | 55 |
fruit extract | 55 |
hydrogen peroxide | 55 |
risk factor | 55 |
antibacterial activities | 55 |
fold increase | 55 |
medicinal plant | 55 |
plant species | 55 |
ethyl acetate | 55 |
ligand binding | 55 |
pc cells | 55 |
atpase activity | 55 |
conformational change | 55 |
antiviral effect | 55 |
bacterial cell | 55 |
compound showed | 55 |
antioxidant activities | 55 |
traditional chinese | 54 |
target protein | 54 |
peripheral blood | 54 |
purifi cation | 54 |
food intake | 54 |
cancer patients | 54 |
pathogenic bacteria | 54 |
tested compounds | 54 |
evaluated using | 54 |
antimycobacterial activity | 54 |
amine reagents | 54 |
two groups | 54 |
newly synthesized | 54 |
human lung | 54 |
specifi city | 54 |
clinical studies | 53 |
free radicals | 53 |
endoplasmic reticulum | 53 |
biological properties | 53 |
structural features | 53 |
hepg cells | 53 |
technical university | 53 |
antibacterial agents | 53 |
specific activity | 53 |
monoclonal antibody | 53 |
pharmacological activities | 53 |
critical role | 53 |
monoclonal antibodies | 53 |
galla chinensis | 53 |
neural stem | 53 |
low concentrations | 53 |
tyrosine kinase | 53 |
rheumatoid arthritis | 53 |
mrna levels | 53 |
synaptic plasticity | 53 |
significant reduction | 52 |
antimicrobial properties | 52 |
modifi cation | 52 |
heart rate | 52 |
terminal region | 52 |
tandem mass | 52 |
biological processes | 52 |
inflammatory cytokines | 52 |
natural product | 52 |
directed mutagenesis | 51 |
high throughput | 51 |
treated cells | 51 |
brown alga | 51 |
significant decrease | 51 |
wound healing | 51 |
brain regions | 51 |
widely distributed | 51 |
rna polymerase | 51 |
investigated using | 51 |
small intestine | 51 |
group i | 51 |
platelet activation | 51 |
recombinant proteins | 51 |
purifi ed | 51 |
life cycle | 51 |
real time | 51 |
peptide bond | 51 |
positive cells | 51 |
ion channels | 51 |
inflammatory response | 51 |
pregnant women | 51 |
human health | 51 |
potent inhibitor | 50 |
preliminary results | 50 |
factor viii | 50 |
human cancer | 50 |
antimicrobial potential | 50 |
two new | 50 |
new compounds | 50 |
hepatocellular carcinoma | 50 |
bacterial strains | 50 |
estrogen receptor | 50 |
vitro anti | 50 |
protein complexes | 50 |
even though | 50 |
pomegranate seed | 50 |
aromatic ring | 50 |
osaka univ | 50 |
inhibition zone | 50 |
also reported | 49 |
university graduate | 49 |
toxic effects | 49 |
highly selective | 49 |
volatile oils | 49 |
using different | 49 |
virus activity | 49 |
ascorbic acid | 49 |
solid support | 49 |
major role | 49 |
hydrogen bonding | 49 |
immune responses | 49 |
human cells | 49 |
protein level | 49 |
higher activity | 49 |
chemical engineering | 49 |
wide variety | 49 |
low toxicity | 48 |
neuronal cells | 48 |
peptides containing | 48 |
induced diabetic | 48 |
kyoto university | 48 |
infl uence | 48 |
high concentrations | 48 |
ko mice | 48 |
also investigated | 48 |
proteins involved | 48 |
aspartic acid | 48 |
bioactive peptides | 48 |
traditional medicine | 48 |
room temperature | 48 |
vivo studies | 48 |
rhus chinensis | 48 |
nucleic acids | 48 |
intrinsically disordered | 48 |
healthy subjects | 48 |
high level | 48 |
structural analysis | 48 |
related compounds | 48 |
chinese medicine | 47 |
granule cells | 47 |
two types | 47 |
blood cells | 47 |
glutamic acid | 47 |
high resolution | 47 |
activity towards | 47 |
cytotoxic effect | 47 |
beneficial effects | 47 |
pharmacological properties | 47 |
crystal structures | 47 |
severe acute | 47 |
last years | 47 |
adipose tissue | 47 |
cov clpro | 47 |
culture medium | 47 |
inhibitory activities | 47 |
dynamics simulations | 47 |
medicinal chemistry | 47 |
thermal stability | 47 |
hydrogen bonds | 47 |
acid sequences | 47 |
dna repair | 47 |
target cells | 46 |
vaccinia virus | 46 |
induced cell | 46 |
research center | 46 |
neurite outgrowth | 46 |
anticonvulsant activity | 46 |
proteolytic activity | 46 |
aqueous solution | 46 |
secondary structures | 46 |
multiple sclerosis | 46 |
marine sponge | 46 |
phenolic acids | 46 |
endothelial cell | 46 |
standard drug | 46 |
full length | 46 |
sequence analysis | 46 |
plasma samples | 46 |
diffusion method | 46 |
aspergillus niger | 46 |
modifi cations | 46 |
structural changes | 46 |
less potent | 45 |
male rats | 45 |
hydrogen bond | 45 |
similar results | 45 |
trypsin inhibitors | 45 |
activity compared | 45 |
showed high | 45 |
tumor growth | 45 |
pyramidal neurons | 45 |
university school | 45 |
new drugs | 45 |
identifi cation | 45 |
dengue virus | 45 |
cell survival | 45 |
allowed us | 45 |
study showed | 45 |
see footnote | 45 |
target genes | 45 |
systematic review | 45 |
density lipoprotein | 45 |
biofilm formation | 45 |
better understanding | 45 |
neuropathic pain | 45 |
human body | 45 |
neuronal cell | 45 |
rat model | 45 |
significantly different | 45 |
innate immunity | 44 |
highly active | 44 |
activity levels | 44 |
plant growth | 44 |
human brain | 44 |
seed extract | 44 |
genes involved | 44 |
brain barrier | 44 |
mouse brain | 44 |
environmental factors | 44 |
large scale | 44 |
genes encoding | 44 |
paulownia tomentosa | 44 |
binding properties | 44 |
apc resistance | 44 |
ankara university | 44 |
dna polymerase | 44 |
cells expressing | 44 |
receptor antagonists | 44 |
measured using | 44 |
least one | 44 |
pyramidal cells | 44 |
cell division | 43 |
binding activity | 43 |
determine whether | 43 |
gene encoding | 43 |
dna methylation | 43 |
activity schedules | 43 |
innate immune | 43 |
time course | 43 |
experimental data | 43 |
per day | 43 |
cellular uptake | 43 |
coiled coil | 43 |
gnrh neurons | 43 |
molecular level | 43 |
molecular modeling | 43 |
analyzed using | 43 |
synthesized using | 43 |
fat diet | 43 |
blood coagulation | 43 |
methanol extract | 43 |
phage display | 43 |
antiviral properties | 43 |
normal cells | 43 |
mg protein | 43 |
aqueous extract | 43 |
serum albumin | 42 |
yoghurt sample | 42 |
science institute | 42 |
immune cells | 42 |
inhibitory potency | 42 |
brown algae | 42 |
play important | 42 |
membrane permeability | 42 |
will discuss | 42 |
glial cells | 42 |
selectivity index | 42 |
four different | 42 |
mutant mice | 42 |
pharmakologie und | 42 |
heart disease | 42 |
oxide synthase | 42 |
cardiovascular diseases | 42 |
molecular basis | 42 |
statistical analysis | 42 |
active peptides | 42 |
gel filtration | 42 |
genomic dna | 42 |
diabetic patients | 41 |
vitro antiviral | 41 |
throughput screening | 41 |
life sciences | 41 |
azadirachta indica | 41 |
kg body | 41 |
small number | 41 |
protein tyrosine | 41 |
hippocampal slices | 41 |
peptide chain | 41 |
minimum inhibitory | 41 |
induces apoptosis | 41 |
anticancer agents | 41 |
oxidative damage | 41 |
induced oxidative | 41 |
energy transfer | 41 |
hydroxyl groups | 41 |
inflammatory effects | 41 |
human umbilical | 41 |
plasmon resonance | 41 |
neem oil | 41 |
adhesion molecules | 41 |
high degree | 41 |
ketonic mannich | 41 |
peptides derived | 41 |
rat liver | 41 |
umbilical vein | 41 |
phase ii | 41 |
amyloid fibrils | 41 |
nmda receptors | 41 |
cyclic peptide | 41 |
ex vivo | 41 |
surface plasmon | 41 |
significant changes | 41 |
broad range | 40 |
differentially expressed | 40 |
three times | 40 |
three groups | 40 |
enzyme inhibition | 40 |
healthy volunteers | 40 |
cancer therapy | 40 |
bacterial growth | 40 |
also increased | 40 |
obtained using | 40 |
potential anti | 40 |
inhibition activity | 40 |
target proteins | 40 |
glycyrrhiza glabra | 40 |
organic solvents | 40 |
remains unclear | 40 |
metabolic engineering | 40 |
serum levels | 40 |
results demonstrated | 40 |
primary structure | 40 |
growth rate | 40 |
ec values | 40 |
protein coupled | 40 |
takes place | 40 |
previously shown | 40 |
peptide sequences | 40 |
healthy controls | 40 |
und toxikologie | 40 |
chemical constituents | 40 |
bond formation | 39 |
cord injury | 39 |
also demonstrated | 39 |
free energy | 39 |
reporter gene | 39 |
glucose levels | 39 |
essential role | 39 |
exclusion chromatography | 39 |
fluorescent protein | 39 |
significantly inhibited | 39 |
sulphated ps | 39 |
structurally related | 39 |
protease inhibitor | 39 |
drug candidates | 39 |
dentate gyrus | 39 |
mitochondrial membrane | 39 |
disulfide bridges | 39 |
expression vector | 39 |
potent activity | 39 |
plasma levels | 39 |
coronary artery | 39 |
dose dependent | 39 |
peptide sequence | 39 |
autoimmune diseases | 39 |
ca region | 39 |
performance liquid | 39 |
chain reaction | 39 |
cell biology | 39 |
acid composition | 39 |
physicochemical properties | 39 |
highly specific | 39 |
hcv rna | 39 |
natural sources | 39 |
amine reagent | 38 |
medical university | 38 |
will present | 38 |
expression profiles | 38 |
based probes | 38 |
metabolic stability | 38 |
potential therapeutic | 38 |
cordyceps militaris | 38 |
rat hippocampal | 38 |
signal peptide | 38 |
light scattering | 38 |
previously described | 38 |
complex formation | 38 |
bovine serum | 38 |
lead compound | 38 |
free amino | 38 |
clinical trial | 38 |
polymerase chain | 38 |
resistant staphylococcus | 38 |
protecting groups | 38 |
helicobacter pylori | 38 |
chemical ligation | 38 |
aminope ptidase | 38 |
active compound | 38 |
i will | 38 |
family members | 38 |
enzymes involved | 38 |
scientific research | 38 |
assay using | 38 |
aerial parts | 38 |
apoptotic cell | 38 |
olfactory bulb | 38 |
will also | 38 |
receptor agonist | 38 |
opioid receptor | 38 |
rhinovirus infection | 38 |
schiff bases | 38 |
showed higher | 38 |
disulfide bonds | 38 |
cells showed | 38 |
may cause | 38 |
osaka university | 38 |
fusion proteins | 38 |
intracellular ca | 37 |
mtlr activity | 37 |
marine compounds | 37 |
carbonic anhydrase | 37 |
increased significantly | 37 |
studies demonstrated | 37 |
adrenergic receptor | 37 |
times higher | 37 |
viral diseases | 37 |
male wistar | 37 |
structural studies | 37 |
glutathione peroxidase | 37 |
cells using | 37 |
crude extracts | 37 |
platelet count | 37 |
rational design | 37 |
oral bioavailability | 37 |
trypanosoma brucei | 37 |
min mg | 37 |
anticoagulant activity | 37 |
chain cleavage | 37 |
findings indicate | 37 |
antifungal agents | 37 |
method using | 37 |
neem cake | 37 |
stress response | 37 |
methyl group | 37 |
signifi cantly | 37 |
may affect | 37 |
respiratory infections | 37 |
arachidonic acid | 37 |
much higher | 37 |
exchange chromatography | 37 |
cell type | 37 |
aliphatic amines | 37 |
outer membrane | 37 |
ntm species | 37 |
ace activity | 36 |
terminal part | 36 |
medical school | 36 |
growth cone | 36 |
research group | 36 |
substantia nigra | 36 |
vein endothelial | 36 |
effi ciency | 36 |
immune function | 36 |
bacterial infections | 36 |
human serum | 36 |
cycle arrest | 36 |
antimicrobial compounds | 36 |
organic compounds | 36 |
higher concentrations | 36 |
catalytic domain | 36 |
significant effect | 36 |
starting point | 36 |
size exclusion | 36 |
inflammatory diseases | 36 |
coupled receptor | 36 |
metabolic syndrome | 36 |
data obtained | 36 |
trypanosomal activity | 36 |
lead compounds | 36 |
without affecting | 36 |
normal human | 36 |
double mannich | 36 |
peptide fragments | 36 |
ion exchange | 36 |
time points | 36 |
science foundation | 36 |
delivery systems | 36 |
glutamate receptor | 35 |
fl ower | 35 |
last decade | 35 |
recent advances | 35 |
carbon source | 35 |
penetrating peptides | 35 |
female rats | 35 |
upper respiratory | 35 |
protein binding | 35 |
marine algae | 35 |
data show | 35 |
will provide | 35 |
biological functions | 35 |
degradation products | 35 |
punicic acid | 35 |
traditionally used | 35 |
may represent | 35 |
recently reported | 35 |
infrared spectroscopy | 35 |
heparan sulfate | 35 |
cardiovascular disease | 35 |
chemical properties | 35 |
dopaminergic neurons | 35 |
nmr spectra | 35 |
recent study | 35 |
biochemical parameters | 35 |
secondary aliphatic | 35 |
biological effects | 35 |
selective inhibitors | 35 |
mycolic acids | 35 |
also tested | 35 |
early stage | 35 |
ring system | 35 |
showed good | 35 |
red blood | 35 |
citric acid | 35 |
living organisms | 35 |
specific antibodies | 35 |
positive correlation | 35 |
carcinoma cells | 35 |
cd cd | 35 |
long term | 35 |
stress conditions | 34 |
confocal microscopy | 34 |
obtained results | 34 |
studies using | 34 |
analysis using | 34 |
bat activity | 34 |
new insights | 34 |
virtual screening | 34 |
tertiary structure | 34 |
studied using | 34 |
mesenchymal stem | 34 |
low activity | 34 |
mononuclear cells | 34 |
amide bond | 34 |
culture conditions | 34 |
synergistic effect | 34 |
two distinct | 34 |
pathogenic fungi | 34 |
replacement therapy | 34 |
moderate activity | 34 |
hiv activity | 34 |
brain development | 34 |
health sciences | 34 |
like receptor | 34 |
food industry | 34 |
basal ganglia | 34 |
ethanolic extract | 34 |
cell penetrating | 34 |
plasminogen activator | 34 |
sedentary behavior | 34 |
sensory neurons | 34 |
glutamate receptors | 34 |
human colon | 34 |
highly expressed | 34 |
reaction mixture | 34 |
growth hormone | 34 |
melanoma cells | 34 |
brain tissue | 34 |
receptor activation | 34 |
compounds isolated | 34 |
coumarin nucleus | 34 |
volatile oil | 34 |
total antioxidant | 33 |
growth factors | 33 |
dependent protein | 33 |
protein interaction | 33 |
transmembrane domain | 33 |
increased risk | 33 |
fusarium oxysporum | 33 |
physiological role | 33 |
dorsal root | 33 |
ray crystallography | 33 |
antiviral compounds | 33 |
structural characterization | 33 |
specifi cally | 33 |
years ago | 33 |
ferulic acid | 33 |
may result | 33 |
chemical modification | 33 |
vascular smooth | 33 |
like proteins | 33 |
protein degradation | 33 |
dna gyrase | 33 |
activity using | 33 |
new therapeutic | 33 |
compounds exhibited | 33 |
fl uorescent | 33 |
kyoto univ | 33 |
acid residue | 33 |
antioxidant status | 33 |
kinetic parameters | 33 |
signalling pathways | 33 |
syncytial virus | 33 |
results will | 33 |
world health | 33 |
probably due | 33 |
elevated levels | 33 |
mice showed | 33 |
vero cells | 33 |
cell apoptosis | 33 |
methanol extracts | 33 |
inflammatory responses | 33 |
infected mice | 33 |
dna replication | 33 |
caffeic acid | 33 |
life science | 33 |
pomegranate peel | 33 |
native chemical | 33 |
vascular endothelial | 33 |
respiratory syncytial | 33 |
dawley rats | 33 |
motor neurons | 33 |
studies suggest | 33 |
middle east | 32 |
human diseases | 32 |
tohoku univ | 32 |
peptide analogues | 32 |
venous thrombosis | 32 |
expression patterns | 32 |
lactate dehydrogenase | 32 |
mosaic virus | 32 |
control cells | 32 |
chemical structures | 32 |
analgesic activity | 32 |
direct interaction | 32 |
data demonstrate | 32 |
catalytic site | 32 |
environmental conditions | 32 |
weight management | 32 |
glycyrrhetinic acid | 32 |
marine organisms | 32 |
electrostatic interactions | 32 |
two compounds | 32 |
recombinant human | 32 |
peptide library | 32 |
diffi cult | 32 |
binding assay | 32 |
treated group | 32 |
point mutations | 32 |
early stages | 32 |
concentration range | 32 |
different mechanisms | 32 |
acid production | 32 |
resonance energy | 32 |
topoisomerase i | 32 |
adhesion molecule | 32 |
weight gain | 32 |
dna synthesis | 32 |
alkaline phosphatase | 32 |
increased expression | 32 |
antiplasmodial activity | 32 |
see scheme | 32 |
experimental conditions | 32 |
pharmacokinetic properties | 32 |
lipid bilayers | 32 |
pathological conditions | 32 |
derived peptides | 32 |
open reading | 32 |
unnatural amino | 32 |
different cell | 32 |
quality control | 32 |
bariatric surgery | 32 |
sesquiterpene lactones | 32 |
social media | 32 |
expressing cells | 32 |
gene transcription | 32 |
examined whether | 32 |
cells treated | 32 |
botrytis cinerea | 32 |
tissue factor | 32 |
fruiting bodies | 32 |
carbon atoms | 31 |
pharmaceutical industry | 31 |
pharmacological activity | 31 |
particular interest | 31 |
many different | 31 |
compounds may | 31 |
tohoku university | 31 |
cell lysates | 31 |
eukaryotic cells | 31 |
kg bw | 31 |
many studies | 31 |
therapeutic target | 31 |
using two | 31 |
powerful tool | 31 |
control mice | 31 |
major components | 31 |
protecting group | 31 |
pharmaceutical sciences | 31 |
tokyo metropolitan | 31 |
also able | 31 |
particle size | 31 |
highly effective | 31 |
chemical stability | 31 |
extracts showed | 31 |
human liver | 31 |
terminal amino | 31 |
health organization | 31 |
double bond | 31 |
chain length | 31 |
least two | 31 |
study revealed | 31 |
old rats | 31 |
anticancer drugs | 31 |
nagoya university | 31 |
physiological conditions | 31 |
carcinoma cell | 31 |
tissue engineering | 31 |
projection neurons | 31 |
ph values | 31 |
quantitative analysis | 31 |
using various | 31 |
membrane fusion | 31 |
active constituents | 31 |
present results | 31 |
control subjects | 31 |
oil encapsulated | 31 |
glucose level | 31 |
increased levels | 31 |
experiments showed | 31 |
authors declare | 31 |
phase i | 31 |
expression pattern | 31 |
tumor suppressor | 31 |
tumour cells | 31 |
juice consumption | 31 |
better understand | 31 |
enzymatic hydrolysis | 30 |
fermentation process | 30 |
recently developed | 30 |
cancer stem | 30 |
take place | 30 |
vitro assays | 30 |
well established | 30 |
biological systems | 30 |
physical distancing | 30 |
nuclear magnetic | 30 |
ca influx | 30 |
phosphorylation sites | 30 |
insulin secretion | 30 |
peptide libraries | 30 |
health problem | 30 |
active sites | 30 |
different stages | 30 |
per week | 30 |
green tea | 30 |
total protein | 30 |
cleavage site | 30 |
bacterial bglu | 30 |
therapeutic strategies | 30 |
dimensional structure | 30 |
new analogues | 30 |
molecular target | 30 |
antibiotic resistance | 30 |
gastrointestinal tract | 30 |
type mice | 30 |
methyl ester | 30 |
currently used | 30 |
protein engineering | 30 |
mammary gland | 30 |
rna replication | 30 |
cancer treatment | 30 |
values ranging | 30 |
long time | 30 |
blood flow | 30 |
ca pyramidal | 30 |
agents synthesis | 30 |
chronic inflammation | 30 |
locomotor activity | 30 |
strand breaks | 30 |
ovarian cancer | 30 |
cytoplasmic membrane | 30 |
protein function | 30 |
mrna level | 30 |
promising results | 30 |
clinical isolates | 30 |
metabolic pathways | 30 |
energy metabolism | 30 |
fluorescence microscopy | 30 |
structure activity | 30 |
hiv infection | 30 |
significant role | 30 |
pivotal role | 30 |
cysteine proteases | 30 |
cholesterol side | 30 |
possible role | 30 |
prepared compounds | 30 |
control groups | 30 |
biological function | 30 |
related genes | 30 |
methanolic extract | 30 |
decreased significantly | 30 |
brain function | 30 |
ethanol extract | 30 |
red alga | 29 |
proteolytic enzymes | 29 |
herbal medicine | 29 |
fl avonoids | 29 |
higher levels | 29 |
phosphate buffer | 29 |
gene transfer | 29 |
various types | 29 |
investigate whether | 29 |
viral dna | 29 |
conformational analysis | 29 |
neural activity | 29 |
mycelial growth | 29 |
new derivatives | 29 |
medium containing | 29 |
neurotrophic factor | 29 |
low doses | 29 |
binding studies | 29 |
auditory cortex | 29 |
dorsal horn | 29 |
based approach | 29 |
fluorescence intensity | 29 |
chlorogenic acid | 29 |
sexual activity | 29 |
colon carcinoma | 29 |
serum samples | 29 |
pg ml | 29 |
ros production | 29 |
chain fatty | 29 |
containing peptides | 29 |
potent inhibitory | 29 |
protective role | 29 |
normal range | 29 |
fl owers | 29 |
therapeutic applications | 29 |
dna sequences | 29 |
hippocampal ca | 29 |
high molecular | 29 |
may help | 29 |
sh domain | 29 |
may serve | 29 |
mesangial cells | 29 |
binding motif | 29 |
inhibitory concentrations | 29 |
also studied | 29 |
adult male | 29 |
chemical structure | 29 |
whole cell | 29 |
endophytic fungus | 29 |
structural information | 29 |
information processing | 29 |
high yield | 29 |
kda protein | 29 |
natural killer | 29 |
two novel | 29 |
develop new | 29 |
years old | 29 |
different doses | 29 |
opioid receptors | 29 |
provide new | 28 |
antimicrobial effects | 28 |
comet assay | 28 |
oxygen transfer | 28 |
organic acids | 28 |
riken brain | 28 |
ion channel | 28 |
among others | 28 |
docking study | 28 |
prion protein | 28 |
term potentiation | 28 |
leydig cells | 28 |
new method | 28 |
neuronal death | 28 |
enveloped viruses | 28 |
much lower | 28 |
low levels | 28 |
mitochondrial dysfunction | 28 |
health care | 28 |
steady state | 28 |
new zealand | 28 |
data analysis | 28 |
guinea pigs | 28 |
protein aggregation | 28 |
glucose tolerance | 28 |
protein concentration | 28 |
surface expression | 28 |
investigated whether | 28 |
linolenic acid | 28 |
cellular functions | 28 |
receptor subtypes | 28 |
time spent | 28 |
limited number | 28 |
helical structure | 28 |
functional properties | 28 |
enzyme inhibitors | 28 |
reading frame | 28 |
liver tissue | 28 |
also exhibited | 28 |
gene therapy | 28 |
adult rats | 28 |
cultured rat | 28 |
vitro study | 28 |
human skin | 28 |
transduction pathways | 28 |
ray diffraction | 28 |
metal ion | 28 |
activity assay | 28 |
two main | 28 |
health benefits | 28 |
acid bacteria | 28 |
plasma glucose | 28 |
healthy individuals | 28 |
rna viruses | 27 |
new anti | 27 |
patients treated | 27 |
novel compounds | 27 |
clinical applications | 27 |
neuronal differentiation | 27 |
single cell | 27 |
mouse models | 27 |
future studies | 27 |
data showed | 27 |
protein complex | 27 |
drug resistant | 27 |
amino groups | 27 |
fully understood | 27 |
frontal cortex | 27 |
liver injury | 27 |
mental health | 27 |
bean trypsin | 27 |
great interest | 27 |
gabaergic neurons | 27 |
will allow | 27 |
inflammatory mediators | 27 |
nerve injury | 27 |
physiological processes | 27 |
highly sensitive | 27 |
water extract | 27 |
antimycobacterial agents | 27 |
dendritic cells | 27 |
different species | 27 |
isolated compounds | 27 |
neural network | 27 |
confi rmed | 27 |
inflammatory effect | 27 |
high fat | 27 |
culture media | 27 |
peritoneal macrophages | 27 |
titration calorimetry | 27 |
high dose | 27 |
intestinal bacteria | 27 |
new york | 27 |
compounds containing | 27 |
kinase activity | 27 |
previous work | 27 |
cultured cells | 27 |
mmpl inhibitors | 27 |
receptor subtype | 27 |
organic chemistry | 27 |
three new | 27 |
coupling reagents | 27 |
increasing concentrations | 27 |
disulfide bond | 27 |
cells compared | 27 |
still unknown | 27 |
assessed using | 27 |
evidence suggests | 27 |
developing countries | 27 |
acute myocardial | 27 |
potential use | 27 |
delivery system | 27 |
trypsin inhibitory | 27 |
fluorescent probe | 27 |
dendritic spines | 27 |
great potential | 27 |
high selectivity | 27 |
programmed cell | 27 |
showed activity | 27 |
kidney cells | 27 |
amyloid formation | 27 |
nervous systems | 27 |
stranded dna | 27 |
results provide | 27 |
mass spectrometric | 27 |
central role | 27 |
physiological functions | 27 |
tumour cell | 27 |
using fmoc | 27 |
also evaluated | 27 |
sedentary behaviour | 27 |
antiviral drug | 27 |
working memory | 27 |
like protein | 27 |
ionic liquids | 27 |
based compounds | 27 |
new generation | 26 |
model peptides | 26 |
factor xa | 26 |
ros generation | 26 |
light chain | 26 |
specific binding | 26 |
antimicrobial agent | 26 |
useful tool | 26 |
clotting time | 26 |
related proteins | 26 |
like activity | 26 |
morphological changes | 26 |
cancer types | 26 |
aqueous solutions | 26 |
binding domains | 26 |
good activity | 26 |
high performance | 26 |
gram negative | 26 |
structural similarity | 26 |
tissue culture | 26 |
linoleic acid | 26 |
transmembrane domains | 26 |
diarrhea virus | 26 |
rna binding | 26 |
high affi | 26 |
action potentials | 26 |
several types | 26 |
se rum | 26 |
reference drugs | 26 |
antioxidant potential | 26 |
listeria monocytogenes | 26 |
research groups | 26 |
ribosomal proteins | 26 |
body mass | 26 |
highest value | 26 |
hydrophobic interactions | 26 |
therapeutic effects | 26 |
extensively studied | 26 |
treated animals | 26 |
point mutation | 26 |
specific inhibitors | 26 |
gut microbiota | 26 |
possible mechanism | 26 |
controlled trial | 26 |
research centre | 26 |
showed moderate | 26 |
crude extract | 26 |
blood vessels | 26 |
antiinflammatory activity | 26 |
based assay | 26 |
surface receptors | 26 |
antiviral agent | 26 |
transition state | 26 |
also examined | 26 |
thyroid hormone | 26 |
dna strand | 26 |
tof mass | 26 |
high purity | 26 |
antibacterial properties | 26 |
studies indicate | 26 |
receptive field | 26 |
androgen receptor | 26 |
cd spectroscopy | 26 |
arabidopsis thaliana | 26 |
glucose uptake | 26 |
column chromatography | 26 |
recently identified | 26 |
acute phase | 26 |
studies indicated | 26 |
isothermal titration | 26 |
inhibition zones | 26 |
influenza viruses | 26 |
also performed | 26 |
steroidal saponins | 26 |
raw material | 26 |
binding pocket | 26 |
plaque reduction | 26 |
polyunsaturated fatty | 26 |
leukemia cells | 25 |
mg dl | 25 |
rna synthesis | 25 |
treated mice | 25 |
specific manner | 25 |
response element | 25 |
aqueous media | 25 |
test drug | 25 |
expression system | 25 |
gram positive | 25 |
multidrug resistance | 25 |
substrate binding | 25 |
disc diffusion | 25 |
human prostate | 25 |
experiments revealed | 25 |
albino rats | 25 |
vitro evaluation | 25 |
vivo activity | 25 |
cultured human | 25 |
potent antiviral | 25 |
mechanism underlying | 25 |
mammalian cell | 25 |
blood plasma | 25 |
patients suffering | 25 |
cultured cordyceps | 25 |
tract infections | 25 |
machine learning | 25 |
enzymatic activities | 25 |
highly potent | 25 |
four times | 25 |
high doses | 25 |
derivatives showed | 25 |
inhibitory potential | 25 |
endothelial growth | 25 |
prothrombin time | 25 |
cysteine residues | 25 |
less toxic | 25 |
next step | 25 |
showed strong | 25 |
low cytotoxicity | 25 |
therapeutic agent | 25 |
charged residues | 25 |
medicinal properties | 25 |
nitrogen atom | 25 |
sulfated polysaccharides | 25 |
university students | 25 |
reduction assay | 25 |
thrombus formation | 25 |
cytokine production | 25 |
proteins may | 25 |
marine pharmacology | 25 |
inhibitory action | 25 |
also shown | 25 |
phaseolus vulgaris | 25 |
total number | 25 |
yeast extract | 25 |
mainly due | 25 |
sleeping sickness | 25 |
protein production | 25 |
cow milk | 25 |
also inhibited | 25 |
class i | 25 |
fold less | 25 |
epigallocatechin gallate | 25 |
binding assays | 25 |
various biological | 25 |
terminal sequence | 25 |
mass spectrometer | 25 |
activity may | 25 |
different parts | 25 |
still unclear | 25 |
topoisomerase ii | 25 |
cell activation | 25 |
free conditions | 25 |
potential antiviral | 25 |
scanning electron | 25 |
final concentration | 25 |
gene regulation | 25 |
terminal fragment | 25 |
interacting protein | 25 |
activity comparable | 25 |
native peptide | 25 |
activity evaluation | 25 |
nmr studies | 25 |
potential target | 25 |
short peptides | 25 |
translational modification | 25 |
streptomyces sp | 25 |
diabetic mice | 24 |
two decades | 24 |
potential role | 24 |
substituted phenyl | 24 |
dependent inhibition | 24 |
promoter region | 24 |
alzheimer disease | 24 |
significant inhibition | 24 |
glutamate release | 24 |
proinflammatory cytokines | 24 |
regression analysis | 24 |
click chemistry | 24 |
per se | 24 |
hydrophobic interaction | 24 |
two major | 24 |
major component | 24 |
transmitter release | 24 |
building block | 24 |
will describe | 24 |
microwave irradiation | 24 |
new type | 24 |
commonly found | 24 |
ser thr | 24 |
group compared | 24 |
chemically synthesized | 24 |
like domain | 24 |
mycolic acid | 24 |
chalcone analogues | 24 |
endophytic fungi | 24 |
purkinje cell | 24 |
several proteins | 24 |
methanolic extracts | 24 |
blood mononuclear | 24 |
also reduced | 24 |
new approach | 24 |
positive charge | 24 |
result suggests | 24 |
relatively low | 24 |
dna sequence | 24 |
protein sequence | 24 |
guinea pig | 24 |
immunomodulatory activity | 24 |
laser desorption | 24 |
phenolic content | 24 |
actin cytoskeleton | 24 |
activity schedule | 24 |
various diseases | 24 |
green fluorescent | 24 |
great importance | 24 |
precursor protein | 24 |
new drug | 24 |
adult rat | 24 |
north america | 24 |
fourier transform | 24 |
new antiviral | 24 |
human cytomegalovirus | 24 |
lung adenocarcinoma | 24 |
mice treated | 24 |
toxic effect | 24 |
mdck cells | 24 |
cells via | 24 |
activity studies | 24 |
ug ml | 24 |
low concentration | 24 |
million people | 24 |
structural biology | 24 |
rna molecules | 24 |
scutellaria baicalensis | 24 |
beta cells | 24 |
host defense | 24 |
ph range | 24 |
different classes | 24 |
chinese medicinal | 24 |
solid state | 24 |
ms analysis | 24 |
neonatal rat | 24 |
expression analysis | 24 |
social isolation | 24 |
model systems | 24 |
bacterial cells | 24 |
local community | 24 |
functional analysis | 24 |
key enzyme | 24 |
increasing interest | 24 |
lesser extent | 24 |
oleic acid | 24 |
remained unchanged | 24 |
cysteine protease | 24 |
mast cell | 24 |
comparative study | 24 |
mass index | 24 |
plant extract | 24 |
acid transport | 24 |
surface area | 24 |
mast cells | 24 |
peptide backbone | 24 |
give rise | 24 |
rhizoctonia solani | 24 |
exhibited significant | 24 |
bl mice | 24 |
insulin sensitivity | 24 |
higher affinity | 24 |
apoptotic cells | 24 |
distilled water | 23 |
glucuronic acid | 23 |
shock proteins | 23 |
research team | 23 |
drug target | 23 |
viral entry | 23 |
female mice | 23 |
neural activities | 23 |
subcellular localization | 23 |
structural elements | 23 |
bactericidal activity | 23 |
human neutrophils | 23 |
negative control | 23 |
lipid metabolism | 23 |
significant correlation | 23 |
inflammatory properties | 23 |
completely abolished | 23 |
microarray analysis | 23 |
cacybp sip | 23 |
virus particles | 23 |
sequence similarity | 23 |
molecular targets | 23 |
help us | 23 |
anticancer activities | 23 |
increased activity | 23 |
sodium alginates | 23 |
polyacrylamide gel | 23 |
willebrand factor | 23 |
also detected | 23 |
new series | 23 |
fever virus | 23 |
different chemical | 23 |
triazole derivatives | 23 |
complex i | 23 |
cerebral ischemia | 23 |
infections caused | 23 |
fungal cell | 23 |
high glucose | 23 |
cell lung | 23 |
glucuronidase inhibitors | 23 |
transcriptional activation | 23 |
thrombin generation | 23 |
molecule inhibitors | 23 |
proteasome system | 23 |
drinking water | 23 |
neuronal migration | 23 |
derived neurotrophic | 23 |
days post | 23 |
survival rate | 23 |
cleavage sites | 23 |
sar studies | 23 |
cdna library | 23 |
catalytic efficiency | 23 |
higher concentration | 23 |
differential expression | 23 |
disease caused | 23 |
liver disease | 23 |
functional role | 23 |
median age | 23 |
well understood | 23 |
neuroprotective effects | 23 |
genetic engineering | 23 |
allow us | 23 |
shed light | 23 |
chronic hepatitis | 23 |
calcium channels | 23 |
significantly improved | 23 |
bglu inhibitors | 23 |
glucuronidase activity | 23 |
fi brils | 23 |
high pressure | 23 |
financial support | 23 |
water molecules | 23 |
novel series | 23 |
thromboplastin time | 23 |
biological membranes | 23 |
time point | 23 |
tyrosine kinases | 23 |
exhibited potent | 23 |
kinase inhibitor | 23 |
serine proteinase | 23 |
electrical stimulation | 23 |
viral proteins | 23 |
ge healthcare | 23 |
tourism industry | 23 |
minimal inhibitory | 23 |
crypt unit | 23 |
fungal strains | 23 |
tissue damage | 23 |
angiotensin i | 23 |
cells infected | 23 |
well documented | 23 |
highest activity | 23 |
plasma ace | 23 |
coagulation factors | 23 |
model membrane | 23 |
diffusion coefficient | 23 |
direct contact | 23 |
small amounts | 23 |
site directed | 22 |
factor receptor | 22 |
using standard | 22 |
vivo study | 22 |
aspergillus flavus | 22 |
stationary phase | 22 |
food products | 22 |
russian science | 22 |
ns protease | 22 |
rich source | 22 |
also determined | 22 |
promoter activity | 22 |
mm tris | 22 |
peptide derivatives | 22 |
artifi cial | 22 |
raw materials | 22 |
helix bundle | 22 |
silica gel | 22 |
drug targets | 22 |
selectivity towards | 22 |
novel peptide | 22 |
leading cause | 22 |
active packaging | 22 |
desorption ionization | 22 |
acid side | 22 |
defi ned | 22 |
apoptotic effects | 22 |
regulatory proteins | 22 |
ethanol production | 22 |
antioxidant enzymes | 22 |
structure prediction | 22 |
water solubility | 22 |
glioma cells | 22 |
protein sequences | 22 |
transmission electron | 22 |
like protease | 22 |
study aimed | 22 |
ml min | 22 |
ubiquitin proteasome | 22 |
high frequency | 22 |
binding capacity | 22 |
cardiac hypertrophy | 22 |
well characterized | 22 |
inflammatory activities | 22 |
total cholesterol | 22 |
calf thymus | 22 |
heavy metals | 22 |
fibril formation | 22 |
human genome | 22 |
different methods | 22 |
brain tissues | 22 |
riken bsi | 22 |
matrix metalloproteinases | 22 |
activity recognition | 22 |
water maze | 22 |
also suggest | 22 |
cationic antimicrobial | 22 |
relationship studies | 22 |
associated protein | 22 |
receptor agonists | 22 |
specific protein | 22 |
keio univ | 22 |
various concentrations | 22 |
induced platelet | 22 |
salicylic acid | 22 |
effi cacy | 22 |
synthesis using | 22 |
screen time | 22 |
ionic strength | 22 |
transforming growth | 22 |
study also | 22 |
novel class | 22 |
negative correlation | 22 |
platelet counts | 22 |
hydrophobic core | 22 |
mass transfer | 22 |
functional roles | 22 |
fear memory | 22 |
transcriptional regulation | 22 |
tourism activities | 22 |
cultural tourism | 22 |
different cancer | 22 |
mic value | 22 |
heavy chain | 22 |
corylifolia extract | 22 |
expression profile | 22 |
lymph nodes | 22 |
sitting time | 22 |
chemical compounds | 22 |
acid analysis | 22 |
soluble fibrin | 22 |
blood loss | 22 |
peptide ligands | 22 |
reaction conditions | 22 |
dynamic light | 22 |
microwave assisted | 22 |
helical conformation | 22 |
peel extract | 22 |
ii diabetes | 22 |
currently available | 22 |
green alga | 21 |
cell bodies | 21 |
nanomolar range | 21 |
recently shown | 21 |
triphosphatase activity | 21 |
computational methods | 21 |
neuronal damage | 21 |
nadph oxidase | 21 |
transgenic mouse | 21 |
growth cones | 21 |
low affinity | 21 |
different time | 21 |
culture system | 21 |
risk assessment | 21 |
cells grown | 21 |
antitumour activity | 21 |
resistant bacteria | 21 |
motor learning | 21 |
university hospital | 21 |
one hand | 21 |
folk medicine | 21 |
worth noting | 21 |
containing two | 21 |
plasmid dna | 21 |
intestinal microbiota | 21 |
high risk | 21 |
older adults | 21 |
might play | 21 |
reference compound | 21 |
translational modifications | 21 |
two peptides | 21 |
patients undergoing | 21 |
relatively high | 21 |
studies will | 21 |
activity synthesis | 21 |
young people | 21 |
carotid artery | 21 |
feline interferon | 21 |
developmental stages | 21 |
oxidant activity | 21 |
low density | 21 |
potentially useful | 21 |
oxidative dna | 21 |
paw edema | 21 |
gene cluster | 21 |
brown seaweed | 21 |
mice lacking | 21 |
viral envelope | 21 |
blood cell | 21 |
medical research | 21 |
ecklonia stolonifera | 21 |
structural diversity | 21 |
vein thrombosis | 21 |
per min | 21 |
synthetic strategy | 21 |
viral genome | 21 |
phase method | 21 |
fatty liver | 21 |
research council | 21 |
group ii | 21 |
polyethylene glycol | 21 |
signalling pathway | 21 |
minor groove | 21 |
basic research | 21 |
activated receptor | 21 |
therapeutic targets | 21 |
microglial cells | 21 |
fmoc tbu | 21 |
multidrug resistant | 21 |
platelet function | 21 |
inducing apoptosis | 21 |
virus infections | 21 |
single molecule | 21 |
tissue samples | 21 |
lysine residues | 21 |
highly variable | 21 |
nagoya univ | 21 |
structural basis | 21 |
largely unknown | 21 |
medical science | 21 |
several different | 21 |
ic mm | 21 |
capillary electrophoresis | 21 |
test compounds | 21 |
natural amino | 21 |
vesicular stomatitis | 21 |
cell density | 21 |
covalently linked | 21 |
defense system | 21 |
ray scattering | 21 |
sequence homology | 21 |
brain injury | 21 |
domain swapping | 21 |
cell signaling | 21 |
much less | 21 |
derivatives containing | 21 |
yeast cells | 21 |
cell activity | 21 |
zoster virus | 21 |
protein molecules | 21 |
releasing hormone | 21 |
clinical symptoms | 21 |
sequence information | 21 |
almost completely | 21 |
iu ml | 21 |
four groups | 21 |
blood levels | 21 |
using molecular | 21 |
well plates | 21 |
blood serum | 21 |
pulmonary disease | 21 |
creative commons | 21 |
inclusion bodies | 21 |
least partially | 21 |
surround suppression | 21 |
rich peptides | 21 |
pomegranate fl | 21 |
potent antioxidant | 21 |
presentation will | 21 |
protein structures | 21 |
arginine residues | 21 |
data collection | 21 |
cell patch | 21 |
pulmonary embolism | 21 |
showed increased | 21 |
phosphatase activity | 21 |
corylifolia linn | 21 |
heterologous expression | 21 |
large numbers | 20 |
activity toward | 20 |
metropolitan institute | 20 |
molecular interactions | 20 |
urine samples | 20 |
triazole ring | 20 |
protein stability | 20 |
bioactive metabolites | 20 |
translation initiation | 20 |
tyrosine phosphorylation | 20 |
drug administration | 20 |
charged amino | 20 |
also play | 20 |
stomatitis virus | 20 |
flow cytometric | 20 |
controlled release | 20 |
mda levels | 20 |
bleeding complications | 20 |
structure elucidation | 20 |
still remains | 20 |
sciatic nerve | 20 |
proteomic analysis | 20 |
enzyme production | 20 |
inhibition assay | 20 |
atopic dermatitis | 20 |
dub inhibitors | 20 |
might contribute | 20 |
novel approach | 20 |
total phenolic | 20 |
antibiotic activity | 20 |
product formation | 20 |
stranded rna | 20 |
peptide derived | 20 |
hiv reverse | 20 |
different proteins | 20 |
coagulation factor | 20 |
structural protein | 20 |
useful tools | 20 |
molecular weights | 20 |
experimental animals | 20 |
water interface | 20 |
food packaging | 20 |
dependent kinase | 20 |
glycopeptide antibiotics | 20 |
cytotoxic agents | 20 |
also called | 20 |
ch ch | 20 |
dna fragmentation | 20 |
axon terminals | 20 |
specific antibody | 20 |
human intestinal | 20 |
pharmacological effects | 20 |
antibacterial effects | 20 |
primary motor | 20 |
integral membrane | 20 |
brain research | 20 |
low ph | 20 |
medium composition | 20 |
filamentous fungi | 20 |
organic solvent | 20 |
tract infection | 20 |
disulfide bridge | 20 |
coumarin scaffold | 20 |
showed potent | 20 |
total rna | 20 |
mes test | 20 |
control sample | 20 |
study using | 20 |
intracellular calcium | 20 |
ray structure | 20 |
significant change | 20 |
salmonella typhimurium | 20 |
fold lower | 20 |
small cell | 20 |
cell layer | 20 |
brain activity | 20 |
bacterial membrane | 20 |
will show | 20 |
treatment options | 20 |
action potential | 20 |
clinical signs | 20 |
active components | 20 |
renal failure | 20 |
mean age | 20 |
xenopus oocytes | 20 |
fast food | 20 |
binding partners | 20 |
plants used | 20 |
protein content | 20 |
enzymatic degradation | 20 |
carboxyl group | 20 |
prepared using | 20 |
er stress | 20 |
resistance mechanisms | 20 |
dpph radical | 20 |
proline residues | 20 |
reporter cell | 20 |
cycle progression | 20 |
ganoderma lucidum | 20 |
reversed phase | 20 |
md simulations | 20 |
homologous recombination | 20 |
sensitive dye | 20 |
artery disease | 20 |
mechanisms involved | 20 |
showed better | 20 |
skeletal muscles | 20 |
bearing mice | 20 |
force field | 20 |
plaque formation | 20 |
coronary heart | 20 |
creative tourist | 20 |
matrix metalloproteinase | 20 |
recently discovered | 20 |
i intron | 20 |
water extracts | 20 |
chinese herbal | 20 |
pechmann condensation | 20 |
supported lipid | 20 |
candidate genes | 20 |
human tumor | 20 |
specific expression | 20 |
first report | 20 |
dna viruses | 20 |
preliminary data | 20 |
pcr analysis | 20 |
frequently used | 20 |
results also | 20 |
fungal pathogens | 20 |
study will | 20 |
benzoic acid | 20 |
binding mode | 20 |
fi nal | 20 |
fi ed | 20 |
vitro model | 20 |
fructus psoraleae | 20 |
attractive target | 20 |
type protein | 20 |
expressed protein | 20 |
high density | 20 |
via inhibition | 20 |
proteinase inhibitors | 20 |
peptide chemistry | 20 |
epidermal growth | 20 |
clinical use | 20 |
cellular proteins | 20 |
plasmodial activity | 20 |
cholera toxin | 20 |
dioscorea species | 20 |
highest antioxidant | 20 |
higher plants | 20 |
human amps | 20 |
fluorescence spectroscopy | 20 |
prenylated coumarins | 20 |
human cell | 20 |
herpes virus | 20 |
aminomethyl function | 20 |
high temperature | 20 |
aromatic aldehydes | 20 |
rna interference | 20 |
human blood | 20 |
physiological ph | 20 |
cytotoxicity towards | 20 |
vitro antibacterial | 20 |
standard deviation | 20 |
based assays | 20 |
stimulatory effect | 20 |
medical sciences | 20 |
different molecular | 20 |
state university | 20 |
developed countries | 20 |
steroid hormones | 20 |
wide spectrum | 20 |
therapeutic approach | 20 |
one study | 19 |
proteolytic degradation | 19 |
transmembrane protein | 19 |
epithelial cell | 19 |
corona virus | 19 |
phenolic hydroxyl | 19 |
underlying mechanism | 19 |
vitro antimicrobial | 19 |
jak stat | 19 |
hcv ns | 19 |
surface antigen | 19 |
vice versa | 19 |
green fluorescence | 19 |
purified using | 19 |
studies suggested | 19 |
target cell | 19 |
phytopathogenic fungi | 19 |
extract showed | 19 |
within days | 19 |
antimalarial drugs | 19 |
xenopus laevis | 19 |
ca channel | 19 |
vivo anti | 19 |
high content | 19 |
type ca | 19 |
neurons showed | 19 |
glutathione reductase | 19 |
rats treated | 19 |
key enzymes | 19 |
chronic obstructive | 19 |
antidiabetic activity | 19 |
many diseases | 19 |
activity probes | 19 |
therapeutic intervention | 19 |
administered orally | 19 |
different conditions | 19 |
van der | 19 |
cell differentiation | 19 |
flow rate | 19 |
disease virus | 19 |
group showed | 19 |
study suggests | 19 |
thin layer | 19 |
chronic diseases | 19 |
elevated plus | 19 |
antitumor activities | 19 |
interacting proteins | 19 |
less effective | 19 |
gives rise | 19 |
xanthine oxidase | 19 |
different groups | 19 |
single amino | 19 |
low temperature | 19 |
study investigated | 19 |
medium supplemented | 19 |
neutral ph | 19 |
endophytic bacteria | 19 |
total oxidant | 19 |
high efficiency | 19 |
table iii | 19 |
study included | 19 |
lipid rafts | 19 |
volatile basil | 19 |
spatial memory | 19 |
using nmr | 19 |
specific inhibitor | 19 |
structural motifs | 19 |
metal binding | 19 |
provide evidence | 19 |
urgent need | 19 |
three major | 19 |
heat stress | 19 |
protein fragments | 19 |
methyl groups | 19 |
treated rats | 19 |
incubation period | 19 |
cationic amino | 19 |
fi eld | 19 |
liver microsomes | 19 |
synaptic vesicles | 19 |
lactobacillus plantarum | 19 |
activity increased | 19 |
antiviral therapy | 19 |
control animals | 19 |
human host | 19 |
candida activity | 19 |
axon guidance | 19 |
inner membrane | 19 |
diseases including | 19 |
low abundance | 19 |
disease states | 19 |
aminoisobutyric acid | 19 |
inhibit viral | 19 |
gene products | 19 |
proteinase inhibitor | 19 |
processes including | 19 |
glucose metabolism | 19 |
financially supported | 19 |
small peptides | 19 |
model membranes | 19 |
three dimensional | 19 |
leaf extracts | 19 |
profi le | 19 |
chemotherapeutic agents | 19 |
side reactions | 19 |
sars coronavirus | 19 |
detailed study | 19 |
negative effects | 19 |
several factors | 19 |
optical imaging | 19 |
colony formation | 19 |
novel mannich | 19 |
catalytic residues | 19 |
human igg | 19 |
fos expression | 19 |
preclinical studies | 19 |
cell extracts | 19 |
pyrrole derivatives | 19 |
conventional antibiotics | 19 |
first study | 19 |
receptor subunits | 19 |
sh domains | 19 |
ca binding | 19 |
coupling reaction | 19 |
shelf life | 19 |
good agreement | 19 |
wistar albino | 19 |
antiviral potential | 19 |
peptide substrates | 19 |
carbon dioxide | 19 |
various cell | 19 |
nose syndrome | 19 |
thiobarbituric acid | 19 |
propidium iodide | 19 |
biotechnology institute | 19 |
alkyl chain | 19 |
synaptic inputs | 19 |
antioxidant effect | 19 |
water soluble | 19 |
fluorescent probes | 19 |
gold nanoparticles | 19 |
binding affinities | 19 |
cytopathic effect | 19 |
transport activity | 19 |
results support | 19 |
mice infected | 19 |
virus entry | 19 |
homology model | 19 |
toxicity studies | 19 |
matrix proteins | 19 |
mental retardation | 19 |
time consuming | 19 |
membrane fluidity | 19 |
inflammatory processes | 19 |
oxidant status | 19 |
cgmp signaling | 19 |
synthesized peptides | 19 |
success rate | 19 |
clinical development | 19 |
linear peptide | 19 |
comparative analysis | 19 |
mediated via | 19 |
cells without | 19 |
like growth | 19 |
leukemia cell | 19 |
double mutant | 19 |
volatile organic | 19 |
lung carcinoma | 19 |
aromatic plants | 19 |
bladder cancer | 19 |
granule cell | 19 |
chemical modifications | 19 |
study shows | 19 |
structural requirements | 19 |
coli bglu | 19 |
abundance scores | 19 |
prolyl oligopeptidase | 18 |
presynaptic terminals | 18 |
human embryonic | 18 |
reaction time | 18 |
clamp recordings | 18 |
antioxidant effects | 18 |
schwann cells | 18 |
cytotoxicity studies | 18 |
fruiting body | 18 |
sodium channel | 18 |
ca signals | 18 |
per cent | 18 |
antithrombin iii | 18 |
visual information | 18 |
double bonds | 18 |
cinnamic acid | 18 |
low dose | 18 |
dairy products | 18 |
septic shock | 18 |
promising candidates | 18 |
acute toxicity | 18 |
cell carcinoma | 18 |
rats fed | 18 |
nitro group | 18 |
thrombin inhibitors | 18 |
strand rna | 18 |
showed inhibitory | 18 |
lower compared | 18 |
contains two | 18 |
carcinogenic cells | 18 |
cells resulted | 18 |
inflammatory drugs | 18 |
japan science | 18 |
showed similar | 18 |
also present | 18 |
large amounts | 18 |
ischemia reperfusion | 18 |
disordered proteins | 18 |
metabolic processes | 18 |
dopamine receptor | 18 |
one patient | 18 |
strong inhibitory | 18 |
initiation factor | 18 |
postnatal day | 18 |
activity data | 18 |
increasing evidence | 18 |
low temperatures | 18 |
structural properties | 18 |
ca channels | 18 |
photosystem ii | 18 |
sodium alginate | 18 |
polypeptide chain | 18 |
chromone derivatives | 18 |
clinical application | 18 |
layer chromatography | 18 |
early diagnosis | 18 |
well tolerated | 18 |
assay showed | 18 |
dominant negative | 18 |
hplc analysis | 18 |
sesquiterpene lactone | 18 |
novel mechanism | 18 |
dilution method | 18 |
proliferative activity | 18 |
three days | 18 |
oxidative phosphorylation | 18 |
conducted using | 18 |
well suited | 18 |
time dependent | 18 |
study group | 18 |
experimental studies | 18 |
carboxamide derivatives | 18 |
ml concentration | 18 |
coding region | 18 |
dry weight | 18 |
randomized controlled | 18 |
visual stimuli | 18 |
gene product | 18 |
neutral red | 18 |
many cases | 18 |
antiprotozoal activity | 18 |
potent antibacterial | 18 |
ethylene glycol | 18 |
peptide conjugates | 18 |
marked increase | 18 |
described previously | 18 |
alternative splicing | 18 |
compound exhibited | 18 |
triple helix | 18 |
pure compounds | 18 |
biosynthetic pathway | 18 |
optical density | 18 |
chromatographic separation | 18 |
age groups | 18 |
hemolytic activity | 18 |
retention time | 18 |
human subjects | 18 |
may act | 18 |
routine activity | 18 |
atomic force | 18 |
carbon sources | 18 |
strong anti | 18 |
aqueous extracts | 18 |
two classes | 18 |
novel anti | 18 |
molecular structure | 18 |
adenylyl cyclase | 18 |
final product | 18 |
brain tumors | 18 |
important step | 18 |
immunomodulatory properties | 18 |
data support | 18 |